Life Science and Lab

Property Type

LIFE SCIENCE AND LAB FOR 1031 EXCHANGES

Life Science and Lab properties represent a specialized real estate sector serving biotechnology, pharmaceutical, and research tenants requiring purpose-built facilities for scientific operations. These properties feature enhanced infrastructure including increased power capacity, specialized HVAC systems, laboratory-grade finishes, and compliance with regulatory requirements that differentiate them from traditional office or industrial space.

For Boston, MA investors, life science real estate holds particular relevance given the region's position as a global hub for biotechnology and pharmaceutical research. The Cambridge-Boston market ranks among the world's premier life science clusters, anchored by major research universities, teaching hospitals, and established biotech and pharma companies. This concentration creates sustained demand for lab space and supports premium rent levels.

Life science properties range from purpose-built lab buildings to converted office or industrial facilities adapted for research use. Investment considerations include tenant credit quality (often venture-backed companies), specialized build-out requirements, and the technical expertise needed to evaluate laboratory infrastructure and compliance.

Explore Property Types

Based in Boston, MA. Nationwide identification support within 45-day and 180-day deadlines.

Why Consider

KEY BENEFITS FOR 1031 EXCHANGE INVESTORS

Premium rents reflecting specialized facility requirements and limited supply

Strong demand fundamentals from growing biotech and pharmaceutical sectors

High tenant retention due to significant build-out costs and operational disruption of relocation

Boston/Cambridge market leadership providing local expertise and deal flow

Long-term lease structures reflecting tenant capital investment in facilities

Growing institutional investor interest supporting liquidity and valuations

Investment Profile

TYPICAL INVESTMENT CHARACTERISTICS

Lease Terms

7-15 years reflecting tenant build-out investment

Lease Structure

Triple Net (NNN) or Modified Gross depending on building type

Tenant Responsibilities

Base building systems often landlord responsibility; tenant handles lab-specific infrastructure

Rent Escalations

Annual increases (2.5-3.5%) with market resets at renewal

Cap Rate Range

5.0% - 6.5% for stabilized assets in core markets; higher for value-add or secondary markets

Tenant Profile

TYPICAL TENANTS

Biotechnology companies (venture-backed startups to established public companies)

Pharmaceutical companies (research and development operations)

Contract research organizations (CROs)

Academic and medical research institutions

Life science incubators and shared lab facilities

Market Factors

LOCATION CONSIDERATIONS

Life science properties cluster around research universities, teaching hospitals, and established biotech hubs. The Boston/Cambridge market dominates nationally, with significant clusters also in San Francisco Bay Area, San Diego, and Research Triangle. Proximity to talent, collaboration opportunities, and venture capital access drives tenant location decisions. For Boston, MA investors, local market expertise provides advantages in evaluating life science opportunities.

Common Questions

FREQUENTLY ASKED QUESTIONS

How do life science properties qualify as 1031 exchange replacement property?+

Life science properties qualify as like-kind replacement property under the same rules as other commercial real estate. The specialized nature of laboratory facilities doesn't affect 1031 eligibility—all real property held for investment or business purposes qualifies. Boston, MA investors can exchange from any real estate type into life science properties. The key is completing proper identification within 45 days and acquisition within 180 days of your relinquished property sale.

What makes Boston/Cambridge life science properties unique for 1031 exchanges?+

The Boston/Cambridge market represents the largest and most established U.S. life science cluster, with premium rent levels reflecting limited supply and exceptional tenant demand. Major pharmaceutical companies, leading biotech firms, and world-class research institutions create a deep tenant base. For investors completing 1031 exchanges, local properties offer exposure to this premier market, though they typically trade at lower cap rates reflecting their desirability and stability.

How do I evaluate tenant credit for life science replacement properties?+

Life science tenant credit evaluation differs from traditional commercial real estate because many tenants are venture-backed companies without traditional credit ratings. We analyze funding history, cash runway, pipeline progress, and management team track record. For publicly traded biotech companies, we review financial statements and market capitalization. Larger pharmaceutical tenants provide investment-grade credit profiles similar to other corporate net lease tenants.

What specialized due diligence is required for life science properties?+

Life science due diligence includes laboratory infrastructure assessment (HVAC capacity, power redundancy, air handling specifications), compliance with biosafety and regulatory requirements, specialized mechanical systems evaluation, and tenant-specific build-out review. We coordinate with life science real estate specialists and technical consultants to evaluate these factors within 1031 exchange timelines. Understanding the tenant's specific research requirements helps assess facility suitability.

Are there unique risks with life science properties that Boston, MA exchange investors should consider?+

Key risks include tenant credit concentration in venture-backed companies, potential for clinical trial failures affecting tenant viability, and specialized facility requirements that may limit re-tenanting options. The specialized nature of lab build-outs can be both a strength (tenant retention) and risk (re-leasing complexity). We help investors evaluate each property's tenant profile, facility flexibility, and market positioning to assess these factors.

Our Capabilities

RELATED SERVICES

Timelines

Relinquished Sale Readiness

Disposition plans that protect the exchange clock and keep proceeds shielded.

Property Paths

Boston Market Scan

Cambridge, Back Bay, and Seaport intel for investors who need local color fast.

Property Paths

Nationwide STNL Identification

Single tenant retail and logistics assets sourced across all 50 states.

Property Paths

Single Tenant Retail Priority List

Convenience, pharmacy, QSR, and daily needs credits ready for diligence.

Markets We Serve

SERVICE AREAS

city

Next Steps

Ready to lock in your 1031 strategy?

Share your life science and lab goals and we will curate identification-ready deals within one business day.

Start Your Briefing Call (617) 766-0619